Evolus, Inc.EOLS
Health Care
$7.41▴ 19.90%
End-of-day close · 2026-08-06
What most investors miss

Trends, drivers and alerts — the full picture.

Profit → Cash
$-36.59MTTM operating cash
Pre-profit

It is still burning cash while pre-profit.

Valuation
Not enough data yet

Not enough valuation history to place this in context.

Revenue growth
+6.7%year over year
Healthy

Revenue is growing at a steady pace.

Leverage
Highdebt to assets
Weak

High leverage relative to its assets.

More coming: dilution / share-count creep.

✦ The read

Evolus, Inc. is pre-profit. It is still burning cash while pre-profit. Revenue is growing at a steady pace. High leverage relative to its assets.

Key numbers
Valuation
EPS (TTM)$-0.67
TTM (trailing 12 months, through fiscal Q1 FY2026)
Profitability
Net margin-14.4%
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$301.79M
TTM (trailing 12 months, through fiscal Q1 FY2026)
🔒 Watchlist alerts — get notified when a signal turnsPro

Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.